CEOInterviews.AI
Start App
Get an email when Mark Cuban gives a new interview
One email per new interview. Unsubscribe in one click.
Mark Cuban
Co-founder; minority owner, Dallas Mavericks, Cost Plus Drugs

Mark Cuban talks about how his drug company is changing healthcare

📅 Apr 09, 2025 WFAA 38 MIN 5832 VIEWS 141 SEGMENTS · 2 SPEAKERS
Mark Cuban is the owner of Cost Plus Drug Co.To that and what is cost plus drugs -- um because costs plus drugs is so important to me um the official name is Mark Cuban Cost ...

Questions asked in this interview

12
  1. 0:00And what is Cost Plus Drugs?
  2. 8:47I mean, what is your level of involvement on a day-to-day basis with the company?
  3. 13:00Well, if it's not for maximizing profit margins, what's in it for you?
  4. 17:14What do we label this new chapter, this new era from Mark Cuban?
  5. 18:44Has your view on legacy changed over the years?
  6. 19:19Yeah, I mean, do you have any regrets along the way?
  7. 22:03You don't have regrets about selling the team?
  8. 24:37Do you think some of that is because they're kind of new to this?
  9. 26:16Are they justified in feeling that way?
  10. 28:38Um, are there other parts of the health care system that can be disrupted?
  11. 34:22How did it get this bad?
  12. 37:49When it's all said and done, you want to be remembered for what?
Interviewer 0:00 ↗
I was doing some research on your, uh, on your favorite social media platform, Twitter/X. Um, your bio says 'dunking on the pharma industry with cost plus drugs.' Nice basketball pun, by the way. But that's it. That's the entire bio. So, um, why did you change to that? And what is Cost Plus Drugs?
Mark Cuban 0:15 ↗
Um, because Cost Plus Drugs is so important to me. Um, the official name is Mark Cuban Cost Plus Drugs, and it's the only company I've ever put my name on, so that tells you something, um, because I wanted everybody to know just how committed I am to it. But kind of the origin story of Cost Plus is interesting. I got a cold email from a doctor, Alex O'Mansky, um, who was based in Denver at the time, and he wanted to create a compounding pharmacy to manufacture injectable generic drugs that were in short supply. Because believe it or not, the drugs — pediatric cancer drugs, um, drugs for pregnant women — that are in short supply and they're generic, you would think that makes no sense at all, um, but that's the reality. And across the world, you know, there are tens of thousands, if not more, of kids with cancer who died because they can't get access to this stuff.
And so he reached out to me and I said, you know what, that's admirable and we can do that, but that's not thinking big enough. And so it was right around the time the pharma bro Martin Shkreli was going to jail, and I was like talking to Alex and I was like, how can this dude just buy up — or how can this dude just raise the price of this drug, Daraprim, to something unreasonable? And what he did was he bought up the entire year's supply of it and did an exclusive. And I'm like, well, that just tells me this industry is messed up. And as I dug in more, it became very apparent that one of the issues was there was zero transparency. And so we created CostPlusDrugs.com here in Dallas, and it's really, really simple.
You go to CostPlusDrugs.com, you put in the name of the medication, and if it's one of the more than 2,500 that we carry, it comes up, tells you what it is, but it shows you our cost. And then it shows you our markup, and um, if you want it delivered by mail, we have a pharmacy, a pharmacist review it, that's $5.05 for shipping and handling. That simple. And then we also have the option now of a pharmacy network to pick it up. And just by doing that, we cut the cost of most generic drugs dramatically, and particularly for a subsection of medications called specialty drugs.
The pharmacy benefit managers — the biggest pharmacy benefit managers — created this scam where they call basic generic drugs specialty drugs if they take care of, you know, advanced diseases like cancer, even though there's nothing special about it, it's just a pill like any other pill. And because of that, they took the license to price these things at astronomical levels. So a drug like imatinib, which is used for leukemia, um, if you just walked into some of the bigger, um, or the biggest, um, pharmacy chains, it'd cost you $2,000. Now maybe they've adjusted and it's $200 to $2,000, or if your employer signed an agreement with them, um, they'll make you buy it through them and it'll be $200 to $2,000. The same drug you go to CostPlusDrugs.com, like I said, we'll show you cost and markup, and it might be $25, $30, depending on the cost.
I mean, we have other drugs. I had a friend email me, um, gosh, been, you know, 18 months now, and he needed this drug called droxydopa, and he had just lost his insurance, and he called up the local pharmacy and it was gonna be $10,000 every three months. I'm like, Landon, let me check to see if we can get it. $63 a month, you know. And there's just — I get emails, you know, weekly if not daily with the same types of stories. And if you think about it, you know what happens when you get a prescription from your doctor? They say, you know, Mark, um, you need this medication, and the next thing they ask you is not, you know, 'Can you afford it? Here's the cost.' It's 'What pharmacy do you use?' That's it.
And so we're trying to change that paradigm so that people can actually be smart shoppers, because those pharmacy benefit managers, working with the insurance companies that they own or own them, have figured out ways to extract as much money from patients as they can.
Interviewer 4:19 ↗
Did you know this much about the drug supply chain when you first...
Mark Cuban 4:23 ↗
No, no. I mean, the company — it's crazy, like there are more acronyms than there are in analytics for sports, you know. Um, it's crazy, and it takes a lot of time still to try to know all this stuff and to find out where the inefficiencies are, because at the end of the day, if you're gonna disrupt an industry like we've done on the pharmaceutical side, you have to understand the industry so you can figure out ways to simplify it. And that's what we've done.
Interviewer 4:48 ↗
What is the purpose? Is it just to simply provide consumers a cheaper alternative to generics and branded...
Mark Cuban 4:54 ↗
Yeah, yeah. I mean, yes, because, you know, I'll tell you about the email that I got just the other day. It was literally — and this isn't the first time — but someone said, 'I have this disease and it's fatal, and this drug can keep me alive longer, um, but I was getting ready to make the decision to not take it because it was going to be $1,000 per month, and I don't want to put my family through the stress of borrowing money or putting it on credit cards just to keep me alive.' How sad is that? That money — just because something is so expensive, they're willing to risk — just to die, like to shorten their life, you know, the life. And so, I mean, it's gut-wrenching that that's what it's come down to.
Because at the end of the day, the pharmacy industry and the health care industry in general is really simple. You know, you go to the doctor, and the doctor says you need a prescription or you need this care, and there's only two questions: how much are they gonna charge you, and how are you gonna pay for it? And the entire industry has become an arbitrage on answering those questions. The pharmacy — the biggest pharmacy benefit managers will manipulate the pricing, um, they'll manipulate, um, how they work with your employer or the insurance companies, and to the end of making everything more expensive. And we're trying to change that by simplifying everything.
Interviewer 6:22 ↗
Where do you hope to see the company in 10, 20 years from now?
Mark Cuban 6:25 ↗
Um, so that health care is basically a right, and that whether it's companies, if they're still providing insurance then, or cities or states or the federal government, it's become so efficient and inexpensive that if I want to make health care for all my employees free, that's up to me because we can afford it. If individuals decide they don't want to get their care through their company, but it's cheap enough that they can make that decision and maybe get paid more, that's up to them. Like for us, for the lives that we cover through my companies, that's exactly what we're doing now. We're doing contracts on health care, and if the care you need is in network, there's no out-of-pocket cost for you. You still pay a premium, but even in other countries that have universal health care, you still pay premiums one way or the other. So I want the markets to become so efficient, not so that we don't have to try to force it one way or the other to, you know, replicate what, you know, England or Germany or whatever does with universal health care. It's a decision that every entity and every individual gets to make.
Interviewer 7:36 ↗
What barriers stand in the way of what you hope to accomplish? Does this current administration affect anything at that level?
Mark Cuban 7:43 ↗
I mean, it might help us actually, um, but the reality is there's one barrier on the pharmacy side. And what that barrier is — you mentioned and alluded to the fact that we don't have all brand drugs, not because we don't want to sell them — and those are the top sellers. Yeah, I mean, well, they're not the top sellers. Generics, from a revenue perspective, yeah, generics are 80 to 90 percent of the number of prescriptions, but, um, the brands are the greatest revenue and most expensive, and those are where people can use a lot of help. But why don't we get them? Because the manufacturers refuse to work with us in the same manner they work with the big PBMs, where with the big PBMs they pay them marketing fees in order to be on their menu of drugs, um, and those are rebates, and they won't do that with us. And the question is why.
And it's not because we don't have access to a lot of patients — we do — but it's because these biggest PBMs effectively threaten them to remove them from the formularies, the menu of options that patients have, if they work with us.
Interviewer 8:47 ↗
CEO Alex. I don't — you call him Alex? You call him Doc? What do you call him — Alex? OK. Yeah, so we talked to him, and we asked kind of what's your level of involvement with the company, and he was telling that the other day you were trying to help to fix a pipe leak, as if, you know, because your landlord situation. I mean, what is your level of involvement on a day-to-day basis with the company?
Mark Cuban 9:08 ↗
Whatever it takes. Yeah, you know, um, half of it is just trying to figure out what other companies are doing, legislative issues, trying to understand the general marketplace like I would with any type of company. Doesn't matter if it's, you know, the Mavs back when I was the governor or, you know, a Shark Tank company. The more I know, the more of an impact I can have, and then using that information and my experience to help make decisions. Because Alex is a rocket scientist — like literally, the dude is like one of the smartest people I've ever met — but he doesn't have the business background that I do, and I don't have, you know, we built one of the few robotics-based manufacturing of drugs in the United States, you know.
So when you mentioned the administration, you know, when it comes to making drugs in the US, we do it, you know, and so we're getting inquiries from all over the world to try to work with us, so that rather than them facing tariffs, they'll come and work through us. And so that's been great, um, and we'll be, you know, we're already growing quickly, but the robotics have only been online a year, and we'll be expanding that.
Interviewer 10:11 ↗
So you're trying to scale up the number that you're creating, or at least manufacturing...
Mark Cuban 10:17 ↗
And what we manufacture. So we're, you know, working now on deals to add biosimilars, where effectively they're generics that are injectables, um, but because they're biosimilars, they take down some of the most expensive drugs. Like Humira went from $8,000 a month to $594 a month, um, via biosimilar. Stelara is going to be another one that has comparable declines in costs. And as more and more biosimilars, um, we're working on deals to manufacture those and other medications, um, and hopefully we can work with the administration to expand that even more rapidly.
Interviewer 10:53 ↗
You mentioned that you're spending a lot of time in meetings and trying to do some sort of fencing, and lots of emails and calls and stuff, and basically lobbying for change.
Mark Cuban 11:02 ↗
Um, yeah, lobbying so much — not so much through the administration per se, not legislatively, but working with CEOs. So for instance, you know, WFAA, um, and your parent company, right? Who do you get your health care from? And there's a 99.99% chance that the CEO really doesn't understand their health care benefits. You leave it to HR, who reports to the CFO, and nobody quite understands all of it. And I'll guarantee you, um, that here at Belo, you're getting ripped off. I don't know what your plan is, but I know if you're working through the biggest insurance companies and PBMs, you are getting ripped off.
Interviewer 11:39 ↗
Are you sure you want to retire from Shark Tank with this sort of energy?
Mark Cuban 11:42 ↗
No, this is great though. I mean, this is the way I've always been, you know. You guys know. I mean, I was talking to Alex about this, and so many people could invest in a company like this and get in it for the right mission at the start, and then you're in it for a few years and revenue is not, you know, peaking. So maybe you start to inch that percentage up and start to notch that up.
Interviewer 12:05 ↗
Is that something that you would ever consider? And would you ever sell this company to...
Mark Cuban 12:14 ↗
Because I haven't taken any outside investors in at all, right? I've written all the checks, and there's a lot of checks, trust me, um, because I don't want it to be about, OK, what's the share price, what's the earnings. I want it to be about up the industry. Period, end of story. You know, if on my tombstone, you know, I don't want it to be about basketball or anything like that. I want it to be 'he messed up the health care industry.' And only because I know this will be on TV, I won't say what I really think, right? Um, because what could be better than that? You know, we trust our doctors, but nobody trusts the financial side of the health care industry. Nobody looks at it and says, 'Wow, this is the way it should be done.' Why are you doing this, Mark? It's the exact opposite — it's like, 'Thank you, please do it.'
Interviewer 13:00 ↗
Well, if it's not for maximizing profit margins, what's in it for you?
Mark Cuban 13:04 ↗
Um, like I said, the satisfaction. You could be a capitalist, a hardcore capitalist like I am. And being a capitalist isn't just about — I think a big misnomer about capitalism is that it's just about how much money you can make. It's about how much satisfaction you can get, and depending on where you are, you know, in your life. When I was younger, if I did this, it would be how much money can I make, because I'd want to, you know, get that big score, change my lifestyle, all that kind of stuff. But where I am now, my next dollar is not gonna change my life, but the satisfaction of helping out, you know, the entire country, and like we've already changed the, um, pharmacy industry.
We've only been shipping for three years, and now the biggest pharmacy benefit managers are going to their corporate clients and saying, 'Yeah, we have a cost plus offering.' It's only been three years, and now they're changing — now they're lying when they say that, their lips are moving, but that's what they're pitching and that's what they're selling. And so, you know, where we'll be going forward, hopefully they won't be there and we will.
Interviewer 14:07 ↗
How much time of your day are you thinking about Cost Plus?
Mark Cuban 14:11 ↗
All day, every day, except when I'm watching Mavs games, um, just because, I mean, I want to win. I want this to change people's lives like it has been on a bigger scale. And really, you know, it's just getting the brand manufacturers to work with us. If there was, you know, if there was anything I'd want the administration to do, is to say, 'Look, you sell to everybody else, we don't even need the same pricing,' you know, because our margins, our markup is only 15%. You don't have to sell it to us for the same thing you sell it to the big PBMs or rebate us for the marketing funds the same way you do the big PBMs. Just give us something. You know, they're just scared because the PBMs are just bull — you know, middlemen bullies.
At least, you know, it seems from — look at it this way, you know, let's just say you sell something to a restaurant and you're on their menu, and there's a competitor that comes in and Mark says, 'I've got a better option than that and I want to sell it to you cheaper.' Well, the restaurant who owns the menu might say no, you know, because I don't want to lose this guy. Or — that's a bad analogy, I didn't say it right, but, um, you get the point. They have these things called formularies, and they're literally telling them, and they won't do it in writing.
I was on, um, I did an interview with the CEO of a major pharmaceutical manufacturer. And I said — and there were all these industry people there — and I said, 'I know you can't say it out loud, but nod your head if you're afraid of losing formulary positioning if you sell to us.' And he just gave me this big smile and he said, 'Next question.'
Interviewer 15:50 ↗
Would you be this involved with Cost Plus if you were still governor of the Mavs?
Mark Cuban 15:55 ↗
Yeah, you would be, yeah, because basketball is great. I love basketball, I always have, always will, will be a Mavs fan no matter what, MFFL, but you know, it's still just a sport. This gives you a deeper level of — well, it's just something. Look, I still have aspirations to have impact, and well, it's great, and you know, I want the same for the Mavs. Even if I was still the — I started this while I was still the governor, you know, so it's not like — but the degree of how it...
Interviewer 16:26 ↗
Oh yeah, yeah, so you were still — you know, if pipes were bursting three years ago, you were helping right there. OK. So nothing's changed in that regard.
Mark Cuban 16:35 ↗
Nothing.
Interviewer 16:37 ↗
Um, has Cost Plus played a role at all in terms of leaving Shark Tank?
Mark Cuban 16:41 ↗
No, not really. That was more family and kids, you know. Friday night, ABC, still watch Shark Tank, uh, but that was because we shoot Shark Tank in June and September. June is when my kids get out of school. I was never there. September, I've got multiple kids with birthdays. I missed my son's birthdays all the time because he was still shooting. And it was one thing when they were tiny, right, but you get to a certain age where you start feeling really guilty about that. And plus I did it for 15 years, you know. Yeah, it's run its course for me.
Interviewer 17:14 ↗
OK, so you sell the Mavs, you're leaving Shark Tank. What do we label this new chapter, this new era from Mark Cuban?
Mark Cuban 17:21 ↗
The beginning, seriously, you know. Just because the wrinkles are there don't mean the wrinkles are in here, right? And so, um, I'm still as aggressive, still as passionate, still want to have as much of an impact. And Cost Plus won't be the last thing I do. There'll be more. There's, you know, I'm still a tech geek and there's a lot going on there. And so, you know, there's other industries yet to be disrupted.
Interviewer 17:45 ↗
You've kind of alluded to it. Is legacy important to you?
Mark Cuban 17:49 ↗
Just people always ask me about it, right? Which just tells me everybody thinks I'm getting old, um, but I don't yet, you know.
Interviewer 17:55 ↗
Well, I just mean it in terms of — I mean, this is the first company for, uh, what is it, um, it's not a nonprofit, but it's a personal benefit, um, PBC, right? So is this the first one that you've owned? So I mean, from afar it seems like he wants to do things that are more for the greater good.
Mark Cuban 18:16 ↗
Because I want to, you know, for sure, it's almost six of one, half dozen of another, just in terms of the intent. But like I said, being a capitalist to me, you know, you can be compassionate, and capitalism is about setting a goal, and if it was financial, that's one thing, but it can also be impact and it can be personal reward. Um, that's capitalism to me. And so I wanted — I want to be a compassionate capitalist from the perspective that, you know, I want to have an impact. That's the reward at this time in my life.
Interviewer 18:44 ↗
Has your view on legacy changed over the years?
Mark Cuban 18:47 ↗
Not really, no.
Interviewer 18:48 ↗
It's like, do you even think about it?
Mark Cuban 18:50 ↗
Not really, you know. I'm not the type to put my name on buildings and that type of stuff, um. I just think I'm still getting started, you know. I've got more experience and more wrinkles, but I'm just getting started. I've got a lot of good to do, and so I want to do it.
Interviewer 19:06 ↗
You're how old right now?
Mark Cuban 19:07 ↗
21, yeah, um.
Interviewer 19:10 ↗
What advice would you give to younger Mark Cuban?
Mark Cuban 19:14 ↗
Um, don't screw it up, or do everything that you did.
Interviewer 19:19 ↗
Yeah, I mean, do you have any regrets along the way?
Mark Cuban 19:22 ↗
Regrets? I've had a few, yeah, of course, um, but you know, nothing dramatic.
Interviewer 19:29 ↗
Yeah, you know, just normal human things. I see that your son joins you at a lot of games now.
Mark Cuban 19:36 ↗
But as many as I can.
Interviewer 19:37 ↗
Well, I know, I mean, I remember the finals. I think I saw you and taking pictures with Jack Harlow. I mean, like, that's gotta be cool to have him along for the ride. What has that father-son bonding...
Mark Cuban 19:49 ↗
Well, I've got two daughters too, so that — yeah, yeah, I don't want to leave out all my kids, yeah, with all my kids. It's just, it's amazing, you know. There's just not enough hours in the day, um, for them, you know. I would spend every minute of every day, um, with them. And you know, it's — and I know you asked me like running for president, you know, when it's all said and done and I'm hopefully 105 years old or 115 years old, you know, and on my last breath, when I look back, I don't want it to be, 'Oh wow, I was president.' I want those last memories to, you know, when they say you relive your life, I want it to be about my kids and being there in their moments. And you know, they're teenagers, and the oldest is 21, it's a fight just to get them to spend time with me, as anybody with teenagers knows, um. And that's the fight I want to fight, that's most important to me.
Interviewer 20:38 ↗
Who's your son's favorite player?
Mark Cuban 20:40 ↗
Um, it was Luka, but now it's Max Christie.
Interviewer 20:44 ↗
He did the hard shift, yeah.
Mark Cuban 20:46 ↗
Because I told him once an MFFL, you know, it's the jersey, because, you know.
Interviewer 20:51 ↗
It was like I saw you, he was, but he was with you for the game in LA.
Mark Cuban 20:55 ↗
Yeah, yeah, OK, um, but like my daughter, um, my middle daughter's, um, was Quentin Grimes, and she, yeah, she was just so upset, um, when we traded Quentin, um.
Interviewer 21:06 ↗
How did your son react to the trade?
Mark Cuban 21:10 ↗
See, about like I did.
Interviewer 21:12 ↗
Did you have to break it to him, or did he — like, I knew five minutes at the most before, and so everybody else was — when it hit, everybody knew. Did you tell him ahead of time, or did he have...
Mark Cuban 21:22 ↗
I didn't know ahead of time.
Interviewer 21:25 ↗
Um, I think that night you told me that you weren't involved with it. So are you like all the way out? Are you not — do they not consult you on anything, or they just...

61 more exchanges in this transcript

Sign in free to read the rest of this interview. No card required.

Sign in to read the full transcript

Cite this transcript

APA, MLA, BibTeX
APA

Cuban, M. (2025, April 9). Mark Cuban talks about how his drug company is changing healthcare [Interview transcript]. WFAA. CEOInterviews.AI. https://ceointerviews.ai/interview/3227859/

MLA

Mark Cuban. "Mark Cuban talks about how his drug company is changing healthcare." WFAA, 9 Apr. 2025. Transcript, CEOInterviews.AI, https://ceointerviews.ai/interview/3227859/.

BibTeX
@misc{cuban2025_3227859,
  author       = {Mark Cuban},
  title        = {Mark Cuban talks about how his drug company is changing healthcare},
  howpublished = {Interview transcript, WFAA. CEOInterviews.AI},
  year         = {2025},
  month        = {apr},
  url          = {https://ceointerviews.ai/interview/3227859/},
  note         = {Speaker-attributed transcript with timestamps}
}